Skip to content

LIDEFARMA

Active
Private limited companyfounded 200818 yrs activeKerkstraat 24A, 9570 Lierde, BelgiumKBO/BCE: BE 0899.688.064
Summary

LIDEFARMA has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €315,147 and a net result of €62,177. Equity is growing by ~7% per year across the filed fiscal years. Its solvency ranks better than 75% of 18606 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability84▲+7
Solvency89▼-10
Growth78=
Track record100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €24,000 at 30 days acceptable
Liquidity ample (current ratio 2.29 against 4.26 in 2024; short-term debt: 33.4% and cash: 20.7% of total assets), and 36.3% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
63.7%
Return on assets
12.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 18 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-08-2026, 25 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
25 d late
2024
on the day
2023
11 d late
2022
30 d late
2021
26 d early
2020
20 d late
2019
28 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 13 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 12 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 7 August 2008, LIDEFARMA was incorporated.1 Total assets went from EUR 297,275 in 2018 to EUR 495,027 in 2025 and headcount from 0.5 to 1 full-time equivalents.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2018 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€315,147▲ 10.4%
2024 · €285,497
Total assets
€495,027▲ 27.9%
2024 · €386,918
Net result
€62,177▲ 140%
2024 · €25,890
Working capital
€213,278▼ 11.6%
2024 · €241,385
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€49,293▲ 2.4%€67,280▲ 36.5%€61,593▼ 8.5%€38,718▼ 37.1%€99,503▲ 157%
Net result€35,885above the sector's middle half▲ 11.7%€56,133above the sector's middle half▲ 56.4%€46,102above the sector's middle half▼ 17.9%€25,890above the sector's middle half▼ 43.8%€62,177above the sector's middle half▲ 140%
Equity€216,671above the sector's middle half▼ 8.5%€272,804above the sector's middle half▲ 25.9%€259,607above the sector's middle half▼ 4.8%€285,497above the sector's middle half▲ 10.0%€315,147above the sector's middle half▲ 10.4%
Total assets€355,586above the sector's middle half▲ 8.5%€460,268above the sector's middle half▲ 29.4%€373,146above the sector's middle half▼ 18.9%€386,918above the sector's middle half▲ 3.7%€495,027above the sector's middle half▲ 27.9%
Debt€138,915▲ 52.4%€187,464▲ 34.9%€113,539▼ 39.4%€101,421▼ 10.7%€179,880▲ 77.4%
Working capital€205,690above the sector's middle half▼ 9.3%€253,848above the sector's middle half▲ 23.4%€215,765above the sector's middle half▼ 15.0%€241,385above the sector's middle half▲ 11.9%€213,278above the sector's middle half▼ 11.6%
Solvency60.9%within the sector's middle half▼ 11.3pp59.3%within the sector's middle half▼ 1.7pp69.6%above the sector's middle half▲ 10.3pp73.8%above the sector's middle half▲ 4.2pp63.7%within the sector's middle half▼ 10.1pp
Current ratio2.83above the sector's middle half▼ 2.303.36above the sector's middle half▲ 0.533.84above the sector's middle half▲ 0.484.26above the sector's middle half▲ 0.422.29within the sector's middle half▼ 1.97
Return on assets (ROA)10.1%within the sector's middle half▲ 0.3pp12.2%above the sector's middle half▲ 2.1pp12.4%above the sector's middle half▲ 0.2pp6.7%within the sector's middle half▼ 5.7pp12.6%within the sector's middle half▲ 5.9pp
Staff (FTE)0.51▲ 100%1.51▼ 33.3%
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25,000€50,000€75,000€100,000Operating result 2021: €49,293€49,293Net result 2021: €35,885€35,885Operating result 2022: €67,280€67,280Net result 2022: €56,133€56,133Operating result 2023: €61,593€61,593Net result 2023: €46,102€46,102Operating result 2024: €38,718€38,718Net result 2024: €25,890€25,890Operating result 2025: €99,503€99,503Net result 2025: €62,177€62,17720212022202320242025€0€25,000€50,000€75,000€100,000Operating result 2023: €61,593€61,600Net result 2023: €46,102€46,100Operating result 2024: €38,718€38,700Net result 2024: €25,890€25,900Operating result 2025: €99,503€99,500Net result 2025: €62,177€62,200202320242025
The operating result recovers in 2025; 2025 is 157% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €495,027
Fixed assets €116,392 ▲ 62.7%
Current assets €378,634 ▲ 20.1%
Equity and liabilities €495,027
Equity €315,147 ▲ 10.4%
Debt €179,880 ▲ 77.4%
Debt's share of the balance-sheet total rises from 26.2% to 36.3%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€123,670▲
2024 · €59,426
Cash flow
€86,344▲
2024 · €46,599
Quick ratio
1.66▼
2024 · 3.06
Debt to equity
0.57▲
2024 · 0.36
ROE
19.7%▲
2024 · 9.1%
Interest coverage
8.79▼
2024 · 31.62
Debt ≤ 1 year
€165,356▲
2024 · €73,994
Debt > 1 year
€14,179▼
2024 · €26,940
Income taxes
€23,254▲
2024 · €12,028
Staff costs
€21,697▼
2024 · €27,477
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 34,679 companies that looked in July 2024 the way this one looks now, 0.6% went bankrupt within 24 months and 95% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
0.6% went bankrupt
3.8% stopped otherwise
95% still going

A further 0.2% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 0.5% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 34,679 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 52 lines
Balance sheet Code20242025
Assets
Total assets20/58€386,918€495,027▲
Fixed assets21/28€71,539€116,392▲
Tangible fixed assets22/27€71,539€116,392▲
Land and buildings22€711€0▼
Plant, machinery and equipment23€1,276€613▼
Furniture and vehicles24€69,551€115,779▲
Current assets29/58€315,379€378,634▲
Stocks and contracts in progress3€88,935€103,742▲
Stocks30/36€88,935€103,742▲
Amounts receivable within one year40/41€73,880€89,359▲
Trade receivables40€55,946€62,994▲
Other amounts receivable41€17,935€26,365▲
Current investments50/53€66,124€81,124▲
Cash at bank and in hand54/58€85,077€102,559▲
Deferred charges and accrued income490/1€1,363€1,849▲
Equity and liabilities
Total equity and liabilities10/49€386,918€495,027▲
Equity10/15€285,497€315,147▲
Contributions10/11€18,600€18,600=
Reserves13€266,897€296,547▲
Distributable reserves133€266,897€296,547▲
Profit (loss) carried forward14€0€0=
Amounts payable17/49€101,421€179,880▲
Amounts payable after more than one year17€26,940€14,179▼
Financial debts170/4€26,940€14,179▼
Amounts payable within one year42/48€73,994€165,356▲
Current portion of amounts payable after more than one year42€20,442€65,659▲
Trade debts44€41,990€49,181▲
Suppliers440/4€41,990€49,181▲
Taxes, remuneration and social security45€11,562€17,989▲
Taxes450/3€8,747€15,222▲
Remuneration and social security454/9€2,816€2,768▼
Other amounts payable47/48-€32,527
Accrued charges and deferred income492/3€486€344▼
Income statement Code20242025
Remuneration, social security and pensions62€27,477€21,697▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20,709€24,167▲
Other operating charges640/8€1,512€1,442▼
Gross operating margin9900€88,416€146,809▲
Operating profit (loss)9901€38,718€99,503▲
Financial income75/76B€1,080€0▼
Recurring financial income75€1,080€0▼
Financial charges65/66B€1,879€14,072▲
Recurring financial charges65€1,879€14,072▲
Profit (loss) for the period before taxes9903€37,918€85,431▲
Income taxes67/77€12,028€23,254▲
Profit (loss) for the period9904€25,890€62,177▲
Profit (loss) for the period to be appropriated9905€25,890€62,177▲
Appropriation of the result
Profit (loss) to be appropriated9906€25,890€62,177▲
Transfer from equity791/2€0€32,527▲
Transfer to equity691/2€25,890€62,177▲
To other reserves6921€25,890€62,177▲
Profit to be distributed694/7€0€32,527▲
Return on contributions (dividend)694€0€32,527▲

The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62€21,788€25,800€23,566€27,477€21,697▼ 21.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€12,217€14,229€20,290€20,709€24,167▲ 16.7%
Other operating charges640/8€1,209€1,264€1,348€1,512€1,442▼ 4.6%
Gross operating margin9900€84,506€108,573€106,797€88,416€146,809▲ 66.0%
Operating profit (loss)9901€49,293€67,280€61,593€38,718€99,503▲ 157%
Financial income75/76B€1,995€3,059€3,093€1,080€0▼ 100%
Recurring financial income75€1,995€3,059€3,093€1,080€0▼ 100%
Financial charges65/66B€1,486€1,243€1,262€1,879€14,072▲ 649%
Recurring financial charges65€1,486€1,243€1,262€1,879€14,072▲ 649%
Profit (loss) for the period before taxes9903€49,802€69,096€63,424€37,918€85,431▲ 125%
Income taxes67/77€13,916€12,962€17,322€12,028€23,254▲ 93.3%
Profit (loss) for the period9904€35,885€56,133€46,102€25,890€62,177▲ 140%
Profit (loss) for the period to be appropriated9905€35,885€56,133€46,102€25,890€62,177▲ 140%
Line20212022202320242025Change
Assets
Total assets20/58€355,586€460,268€373,146€386,918€495,027▲ 27.9%
Fixed assets21/28€37,700€98,816€81,485€71,539€116,392▲ 62.7%
Tangible fixed assets22/27€37,700€98,816€81,485€71,539€116,392▲ 62.7%
Land and buildings22€25,511€17,245€8,978€711€0▼ 100%
Plant, machinery and equipment23€1,517€2,602€1,939€1,276€613▼ 52.0%
Furniture and vehicles24€10,671€78,969€70,569€69,551€115,779▲ 66.5%
Current assets29/58€317,886€361,452€291,661€315,379€378,634▲ 20.1%
Stocks and contracts in progress3€76,810€81,623€84,467€88,935€103,742▲ 16.6%
Stocks30/36€76,810€81,623€84,467€88,935€103,742▲ 16.6%
Amounts receivable within one year40/41€98,538€139,668€52,652€73,880€89,359▲ 21.0%
Trade receivables40€39,229€30,566€47,405€55,946€62,994▲ 12.6%
Other amounts receivable41€59,308€109,101€5,247€17,935€26,365▲ 47.0%
Current investments50/53€12,125€30,125€48,125€66,124€81,124▲ 22.7%
Cash at bank and in hand54/58€130,413€108,549€103,689€85,077€102,559▲ 20.5%
Deferred charges and accrued income490/1-€1,488€2,728€1,363€1,849▲ 35.7%
Equity and liabilities
Total equity and liabilities10/49€355,586€460,268€373,146€386,918€495,027▲ 27.9%
Equity10/15€216,671€272,804€259,607€285,497€315,147▲ 10.4%
Contributions10/11€18,600€18,600€18,600€18,600€18,600=
Reserves13€198,071€254,204€241,007€266,897€296,547▲ 11.1%
Non-distributable reserves130/1€1,860€1,860----
Reserves not available under the articles1311€1,860€1,860----
Distributable reserves133€196,211€252,344€241,007€266,897€296,547▲ 11.1%
Profit (loss) carried forward14€0€0€0€0€0-
Amounts payable17/49€138,915€187,464€113,539€101,421€179,880▲ 77.4%
Amounts payable after more than one year17€26,719€79,826€37,438€26,940€14,179▼ 47.4%
Financial debts170/4€26,719€79,826€37,438€26,940€14,179▼ 47.4%
Amounts payable within one year42/48€112,196€107,604€75,895€73,994€165,356▲ 123%
Current portion of amounts payable after more than one year42€10,616€10,623€31,599€20,442€65,659▲ 221%
Trade debts44€34,163€26,072€29,943€41,990€49,181▲ 17.1%
Suppliers440/4€34,163€26,072€29,943€41,990€49,181▲ 17.1%
Taxes, remuneration and social security45€11,491€14,982€14,354€11,562€17,989▲ 55.6%
Taxes450/3€7,287€9,202€11,602€8,747€15,222▲ 74.0%
Remuneration and social security454/9€4,204€5,781€2,752€2,816€2,768▼ 1.7%
Other amounts payable47/48€55,926€55,926€0-€32,527-
Accrued charges and deferred income492/3-€34€206€486€344▼ 29.2%
Line20212022202320242025Change
Profit (loss) for the period9904€35,885€56,133€46,102€25,890€62,177▲ 140%
+ Depreciation and write-downs630€12,217€14,229€20,290€20,709€24,167▲ 16.7%
Operating cash flow (approximation)€48,102€70,362€66,392€46,599€86,344▲ 85.3%
Investment in fixed assets (approximation)--€75,345-€2,959-€10,762-€69,021▼ 541%
Change in cash--€21,864-€4,860-€18,612€17,482▲ 194%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
25-08
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 25 days late
2025
31-12
Financial Highest result since 2018net €62,177 ▲140%
Operating result €99,503, net result €62,177, both a record.
31-07
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
11-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 11 days late
2023
30-08
NBB filing Annual accounts filed
fiscal year 2022 · micro schema · 30 days late
2022
05-07
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
2021
20-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 20 days late
2020
28-08
NBB filing Annual accounts filed
fiscal year 2019 · micro schema · 28 days late
2019
31-12
Financial Equity above €200,000Eq €204,581 ▲4.3%
2 profitable years in a row build equity to €204,581.
28-08
NBB filing Annual accounts filed
fiscal year 2018 · micro schema · 28 days late
2018
23-07
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
07-07
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Lierde · 1 establishment unit since 2008
seat establishment The establishment unit on the map
Ground area
1,834 m²
Building footprint
546 m²
Volume, LiDAR
3,866 m³
2 parcels, Flanders · tallest building 13.0 m, ±3 floors. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 establishment unit
Lidefarma
Kerkstraat 32, 9570 LierdeRetail sale of pharmaceutical products
since 20082.173.076.449
2 parcels
Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
45004A0731/00G000 Flanders 1,046 m² 1 · 291 m² 10.9 m · 2 fl.
45004B0416/00W000 Flanders 788 m² 1 · 255 m² 12.9 m · 3 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,492 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded07-08-2008
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
64210Activities of holding companies
70200Business and other management consultancy
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0899688064
Also 9925:BE0899688064
Registered 24-11-2023

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.